Bioceres Crop Solutions
BIOX
22 hedge funds and large institutions have $17M invested in Bioceres Crop Solutions in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 1 closing their positions.
300% more call options, than puts
Call options by funds: $1.9M | Put options by funds: $474K
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
5% more funds holding
Funds holding: 21 → 22 (+1)
0.02% less ownership
Funds ownership: 3.07% → 3.05% (-0.02%)
5% less capital invested
Capital invested by funds: $17.8M → $17M (-$805K)
14% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 7
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UIC
Uniplan Investment Counsel
Milwaukee,
Wisconsin
|
+$1.06M |
| 2 |
BlackRock
New York
|
+$439K |
| 3 |
Marshall Wace
London,
United Kingdom
|
+$189K |
| 4 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
+$74.6K |
| 5 |
Morgan Stanley
New York
|
+$33K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
APA
Arisaig Partners (Asia)
Singapore
|
-$532K |
| 2 |
JP Morgan Chase
New York
|
-$532K |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$408K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$201K |
| 5 |
FA
Friess Associates
Greenville,
Delaware
|
-$121K |
BIOX Hedge Fund Activity: Q1 2022 in Review
22 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Bioceres Crop Solutions (BIOX) for Q1 2022, worth a combined $17M — down 4.5% from $17.8M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new BIOX positions and 1 closed out — a net gain of 1 holder — while 6 added to existing stakes and 7 trimmed.
The largest buyer was Uniplan Investment Counsel, adding an estimated $1.06M. The largest seller was Arisaig Partners (Asia), cutting an estimated $532K.
- 22 institutional investors held Bioceres Crop Solutions (BIOX) as of Q1 2022, up from 21 in Q4 2021.
- Funds reported $17M of Bioceres Crop Solutions stock for Q1 2022, down 4.5% quarter-over-quarter.
- 2 funds opened new Bioceres Crop Solutions positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest Bioceres Crop Solutions buyer in Q1 2022 was Uniplan Investment Counsel, an estimated $1.06M added.
- The largest Bioceres Crop Solutions seller in Q1 2022 was Arisaig Partners (Asia), an estimated $532K sold.
Based on aggregated 13F filings for Q1 2022.